Skip to main content

Table 1 Univariate analyses of risk factors associated with DVT following ankle fracture surgeries

From: Incidence of deep venous thrombosis (DVT) of the lower extremity in patients undergoing surgeries for ankle fractures

Variables

Number (%) of DVT (n = 38)

Number (%) of non-DVT (n = 1413)

p

Gender (male)

19 (50.0)

806 (57.0)

0.387

Age (years)

55.6 ± 14.6

43.4 ± 15.0

< 0.001

 18–44

11 (28.9)

764 (54.1)

0.001

 45–64

18 (47.4)

515 (36.4)

 

 65 or older

9 (23.7)

134 (9.5)

 

Living place

  

0.789

 Rural

23 (60.5)

777 (55.1)

 

 Urban

15 (39.5)

635 (44.9)

 

BMI (kg/m2)

24.5 ± 3.6

25.9 ± 4.1

0.181

 18.5–23.9

11 (28.9)

414 (29.3)

 

 < 18.5

2 (5.3)

25 (1.8)

 

 24.0–27.9

18 (47.4)

608 (43.0)

 

 ≥ 28.0

7 (18.4)

366 (25.9)

 

Cigarette smoking

9 (23.7)

212 (15.0)

0.142

Alcohol consumption

11 (28.9)

387 (27.4)

0.832

Diabetes mellitus

12 (31.6)

179 (12.7)

0.001

Hypertension

9 (23.7)

183 (13.0)

0.054

Chronic heart disease

3 (7.9)

65 (4.6)

0.343

History of allergies to any medications

8 (21.1)

202 (14.3)

0.243

History of any surgery

5 (13.2)

109 (7.7)

0.218

Injury mechanism (high energy)

10 (26.3)

284 (20.1)

0.347

Fracture location

  

0.757

 Unimalleolar

17 (44.7)

656 (45.8)

 

 Bimalleolar

7 (18.4)

323 (22.5)

 

 Trimalleolar

14 (36.8)

454 (31.7)

 

Accompanied dislocation or subluxation

9 (23.7)

258 (17.9)

0.361

Preoperative stay

7.7 ± 3.2

5.3 ± 3.6

< 0.001

Total hospital stay

23.0 ± 7.8

16.1 ± 14.7

0.004

Anesthesia (general)

19 (50.0)

271 (19.2)

< 0.001

ASA class

  

0.033

 I

4 (10.5)

250 (17.7)

 

 II

25 (65.8)

1011 (71.5)

 

 III or above

9 (23.7)

152 (10.8)

 

Operation timing

  

0.293

 Day

38 (100)

1373 (97.2)

 

 Night

0

40 (2.8)

 

Type of fracture reduction

  

0.780

 Closed

1 (2.6)

49 (3.5)

 

 Open

37 (97.4)

1364 (96.5)

 

Fixation type

   

 Screw or pins only

0

73 (5.2)

0.150

 Plate and screws

38 (100)

1340

 

Bone grafting

2 (5.3)

52 (3.7)

0.611

Intraoperative bleeding

254.2 ± 349.6

167.1 ± 213.9

0.014

Perioperative blood transfusion (yes)

3 (7.9)

44 (3.1)

0.101

Surgical duration

134.9 ± 74.4

130.7 ± 58.2

0.664

TP (< 60 g/L)

12 (31.6)

245 (17.3)

0.023

ALB (< 35 g/L)

10 (26.3)

171 (12.1)

0.009

Intraoperative prophylactic use of antibiotics

38 (100)

1332 (94.3)

0.129

Postoperative use of antibiotics

36 (94.7)

1304 (92.3)

0.575

FBG (> 6.1 mmol/L)

15 (39.5)

398 (28.2)

0.127

TC (> 5.2 mmol/L)

13 (34.2)

237 (16.8)

0.005

TG (> 1.7 mmol/L)

7 (18.4)

270 (19.1)

0.915

LDL-C (> 3.37 mmol/L)

11 (28.9)

250 (17.7)

0.075

HDL-C (< 1.1 mmol/L)

12 (31.6)

511 (36.2)

0.561

VLDL (> 0.78 mmol/L)

6 (15.8)

263 (18.6)

0.659

WBC (> 10 × 109/L)

8 (21.1)

373 (26.4)

0.460

NEUT (> 6.3 × 109/L)

17 (44.7)

603 (42.7)

0.726

LYM (< 1.1 × 109/L)

20 (52.6)

273 (19.3)

< 0.001

RBC (< lower limit)

15 (39.5)

271 (19.2)

0.002

HGB (< lower limit)

15 (39.5)

269 (19.0)

0.002

HCT (< lower limit)

22 (57.9)

563 (39.8)

0.025

PLT (> 300 × 109/L)

6 (15.8)

256 (18.1)

0.713

PDW (> 18.1%)

2 (5.3)

18 (1.3)

0.037

RDW (> 16.5%)

4 (10.5)

52 (3.7)

0.031

D-dimer (> 0.3 mg/L)

30 (81.1)

860 (60.9)

0.013

  1. DVT deep venous thrombosis; BMI body mass index; ASA American Society of Anesthesiologists; RBC red blood cell, reference range: female, 3.5–5.0 × 1012/L, males, 4.0–5.5 × 1012/L; HGB hemoglobin, reference range: females, 110–150 g/L, males, 120–160 g/L; FBG fasting blood glucose; HCT hematocrit, 40–50%; WBC white blood cell, NEUT neutrophile; LYM lymphocyte; PLT platelet, 100–300 × 109/L; TP total protein; ALB albumin; RDW red cell distribution width; PDW platelet distribution width; TC total cholesterol; TG triglyceride; LDL-C, low-density lipoprotein; HDL-C high-density lipoprotein; VLDL very low-density lipoprotein